Juvenile dermatomyositis (JDM) sine myositis
Schulz A+4 more
doaj +1 more source
Over Activation of IL-6/STAT3 Signaling Pathway in Juvenile Dermatomyositis. [PDF]
Zheng Q, Wang Z, Tan Y, Zhu K, Lu M.
europepmc +1 more source
Advances in Juvenile Dermatomyositis: Pathophysiology, Diagnosis, Treatment and Interstitial Lung Diseases-A Narrative Review. [PDF]
Kobayashi I.
europepmc +1 more source
Physical activity and quality of life of children and adolescents with juvenile idiopathic arthritis, juvenile systemic lupus erythematosus and juvenile dermatomyositis during the COVID-19 pandemic. [PDF]
Soares R+5 more
europepmc +1 more source
Clinical characteristics and prognostic factor in juvenile dermatomyositis: data of the Spanish registry. [PDF]
Carriquí-Arenas S+19 more
europepmc +1 more source
Familial clustering of dysbiotic oral and fecal microbiomes in juvenile dermatomyositis. [PDF]
Koester ST+16 more
europepmc +1 more source
Related searches:
Dermatomyositis und juvenile Dermatomyositis
Zeitschrift für Rheumatologie, 2022Dermatomyositis (DM) is an inflammatory multisystem disease of unknown etiology, which can already occur in children but first onset can also be in older adulthood. Myalgia and muscle weakness can occur later in the course of the disease or even be completely absent in some forms.
F. Dressler, B. Maurer
semanticscholar +3 more sources
Rapid Improvement in Recalcitrant Cutaneous Juvenile Dermatomyositis With Anifrolumab Treatment.
JAMA dermatology, 2023This case report describes a 14-year-old girl with juvenile dermatomyositis who presented with a 6-year history of a pruritic, photosensitive eruption involving her face, neck, trunk, and extremities and was successfully treated with anifrolumab.
Katharina S. Shaw+6 more
semanticscholar +1 more source